Insider Trading & Ownership - BIOS Fund I LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BIOS Fund I LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-14
Sale(A)
2024-08-20
8:45 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
24,999$8$199,992131,248
(Indirect)
View
2024-08-14
Purchase
2024-08-14
8:44 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
500,000$8$4,000,000216,083
(Indirect)
View
2024-08-14
Sale
2024-08-14
8:44 pm
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
24,999$9$224,991216,083
(Indirect)
View
2024-05-23
Sale
2024-05-28
4:30 pm
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
30,000$6.3033$189,100747,049
(Indirect)
View
2024-02-27
Sale
2024-02-29
9:54 pm
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
144,000$4.6965$676,294753,428
(Indirect)
View
2024-01-17
Sale
2024-01-19
4:31 pm
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
58,889$4.2$247,334784,013
(Indirect)
View
2023-11-29
Sale
2023-12-01
06:01 am
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
145,348$3.44$499,9971,170,117
(Indirect)
View
2023-06-21
Purchase
2023-06-23
9:38 pm
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
2,297,490$1.3058$3,000,000527,195
(Indirect)
View
2022-11-28
Purchase
2022-11-29
07:02 am
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
10% Owner
16,064$2.6497$42,5653,151,266
(Indirect)
View
2022-11-16
Purchase
2022-11-17
07:00 am
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
71,000$1.4$99,4003,149,395
(Indirect)
View
2022-11-15
Purchase
2022-11-16
07:00 am
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
1,500,000$1.2$1,800,0003,141,126
(Indirect)
View
2022-11-08
Sale
2022-11-09
9:37 pm
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
350,000$4.4$1,540,000190,230
(Indirect)
View
2022-09-02
Sale
2022-09-07
4:55 pm
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
6,445$5.2$33,5141,889,456
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-08-14
Exercise
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
37,951$5.27216,083
(Indirect)
View
2024-08-14
Exercise
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
37,951$0216,083
(Indirect)
View
2024-08-12
Option Award
2024-08-14
8:44 pm
N/A
2034-08-12
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
15,000$0216,083
(Indirect)
View
2024-08-14
Conversion
2024-08-14
8:44 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
9,380,699$0216,083
(Indirect)
View

Ownership
2024-08-12
6:29 pm
N/A
N/A
ACTUATE THERAPEUTICS INC.ACTUKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
0$08,835,435
(Indirect)
View
2024-06-07
Option Award
2024-06-11
9:32 pm
N/A
2034-06-07
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
10% Owner
8,500$06,023,000
(Direct)
View
2024-01-17
Exercise
2024-01-19
4:31 pm
N/A
N/A
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
79,021$3.13784,013
(Indirect)
View
2024-01-17
Exercise
2024-01-19
4:31 pm
2019-03-07
2024-03-07
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
79,021$0784,013
(Indirect)
View
2023-11-08
Option Award
2023-11-13
09:47 am
N/A
N/A
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
10% Owner
500,095$1.056,012,000
(Indirect)
View
2023-06-21
Conversion
2023-06-23
9:38 pm
N/A
N/A
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
6,807,032$0527,195
(Indirect)
View

Ownership
2023-06-15
5:55 pm
N/A
N/A
Azitra IncAZTRKreis Leslie W.
Cavu Advisors LLC
Cavu Management LP
BIOS Fund I LP
BIOS Fund I QP LP
Bios Equity Partners LP
BIOS Fund II LP
BIOS Fund II NT LP
BIOS Fund II QP LP
Bios Equity Partners II LP
10% Owner
0$04,535,218
(Indirect)
View
2023-06-09
Option Award
2023-06-13
8:01 pm
N/A
2033-06-09
COGNITION THERAPEUTICS INCCGTXFletcher Aaron G.L.
BIOS Capital Management LP
BIOS Advisors GP LLC
Bios Equity Partners LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Memory SPV I LP
Bios Equity Partners II LP
BIOS Fund II LP
BIOS Fund II QP LP
Director
10% Owner
6,000$05,511,905
(Direct)
View
2022-09-02
Exercise
2022-09-07
4:55 pm
2018-12-17
2028-12-16
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
32,538$01,889,456
(Indirect)
View
2022-09-02
Exercise
2022-09-07
4:55 pm
N/A
N/A
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
32,538$1.031,889,456
(Indirect)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
N/A
N/A
Lantern Pharma Inc.LTRNKreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779$3.131,292,887
(Indirect)
View
2022-03-17
Exercise
2022-03-21
6:11 pm
2017-03-17
2022-03-17
Lantern Pharma Inc.LTRNKreis Leslie W.
Bios Equity Partners LP
Cavu Management LP
BIOS Capital Management LP
Cavu Advisors LLC
BIOS Advisors GP LLC
Fletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
Director
10% Owner
95,779$01,292,887
(Indirect)
View
2021-10-13
Conversion(A)
2022-02-01
7:24 pm
N/A
N/A
COGNITION THERAPEUTICS INCCGTXBIOS Memory SPV I LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
10% Owner
1,424,014$01,424,014
(Direct)
View

Ownership(A)
2022-02-01
6:44 pm
N/A
N/A
COGNITION THERAPEUTICS INCCGTXBIOS Memory SPV I LP
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
BIOS Memory SPV II LP
BIOS Fund III LP
BIOS Fund III QP LP
BIOS Fund III NT LP
10% Owner
0$01,424,014
(Direct)
View
2020-06-15
Other
2020-06-16
7:30 pm
N/A
2030-06-14
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
9,135$098,657
(Indirect)
View
2020-06-15
Conversion
2020-06-16
7:30 pm
N/A
N/A
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
2,293,804$098,657
(Indirect)
View

Ownership
2020-06-10
8:23 pm
N/A
N/A
Lantern Pharma Inc.LTRNFletcher Aaron G.L.
BIOS Fund I LP
BIOS Fund I QP LP
BIOS Fund II LP
BIOS Fund II QP LP
BIOS Fund II NT LP
Bios Equity Partners LP
Bios Equity Partners II LP
BIOS Capital Management LP
BIOS Advisors GP LLC
10% Owner
0$01,968,478
(Indirect)
View
(A) Indicate amendment filing.